ADC bioconjugation manufacturing joins a payload so toxic it needs the top containment class (OEB 5) to an antibody, then checks drug-to-antibody ratio and free payload. Capacity sits with a handful of contractors such as Lonza, WuXi XDC and Samsung Biologics, so long queues and China-based exposure shape who can develop ADCs.
ADC manufacturing needs high-potency containment (OEB 5), conjugation chemistry, and analytics for drug-to-antibody ratio and free payload. Capacity is concentrated in a handful of CDMOs: Lonza (Visp, incl. Synaffix technology), WuXi XDC, Samsung Biologics (new ADC plant 2025), Piramal Pharma Solutions, Abzena, Sterling, and Merck KGaA's MilliporeSigma. Payload-linker supply (MedChemExpress, Levena, Kelun's in-house) and lyophilised fill-finish are the other choke points.
Antibody produced by CHO cell culture; payload-linker synthesised under containment; site-specific or stochastic conjugation, purification, and DAR analytics; aseptic fill.
Nothing recorded yet: a foundation, or a gap to fill.
Dependencies are what this technology cannot be delivered without: manufacturing steps, instruments, software, upstream methods. See its full chain on the map.
Query for this technology: (TITLE:"ADC bioconjugation manufacturing" OR ABSTRACT:"ADC bioconjugation manufacturing" OR TITLE:"CDMOs" OR ABSTRACT:"CDMOs") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about ADC bioconjugation manufacturing (CDMOs), not a curated reading list.
Shares Samsung Biologics, CDMO (contract development and manufacturing organisation), Lonza, Antibody manufacturing (CHO bioprocessing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares CDMO (contract development and manufacturing organisation) and the tag supporting.
Shares CDMO (contract development and manufacturing organisation), Lonza and the tag supporting.
Shares BIOSECURE Act and the tag supporting.
Shares BIOSECURE Act and the tag supporting.
Shares Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.